BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND HOXA11, HOX1, 3207, ENSG00000005073, HOX1I, P31270
19 results:

  • 1. A novel tumor staging system incorporating cN status for stratifying early stage esophageal squamous cell carcinoma patients after trimodal therapy.
    Li X; Luan S; Zhang C; Kong W; Xiao X; Zhang H; Zhou J; Yang Y; Xu Y; Qiang Y; Fang P; Shen Y; Yuan Y
    Eur J Surg Oncol; 2024 Jan; 50(1):107264. PubMed ID: 37977046
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. lncRNA hoxa11-AS maintains the stemness of oral squamous cell carcinoma stem cells and reduces the radiosensitivity by targeting miR-518a-3p/PDK1.
    Li B; Lv Y; Zhang C; Xiang C
    J Oral Pathol Med; 2023 Mar; 52(3):216-225. PubMed ID: 36661031
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. An Axis between the Long Non-Coding RNA
    Nakashima C; Fujiwara-Tani R; Mori S; Kishi S; Ohmori H; Fujii K; Mori T; Miyagawa Y; Yamamoto K; Kirita T; Luo Y; Kuniyasu H
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142607
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Long non-coding RNA hoxa11 antisense RNA upregulates spermatogenesis-associated serine-rich 2-like to enhance cisplatin resistance in laryngeal squamous cell carcinoma by suppressing microRNA-518a.
    Shen N; Duan X; Feng Y; Zhang J; Qiao X; Ding W
    Bioengineered; 2022 Jan; 13(1):974-984. PubMed ID: 34974809
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. In silico interaction of HOX cluster-embedded microRNAs and long non-coding RNAs in oral cancer.
    Padam KSR; Basavarajappa DS; Shenoy US; Chakrabarty S; Kabekkodu SP; Hunter KD; Radhakrishnan R
    J Oral Pathol Med; 2022 Jan; 51(1):18-29. PubMed ID: 34358375
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.
    Dighe SG; Chen J; Yan L; He Q; Gharahkhani P; Onstad L; Levine DM; Palles C; Ye W; Gammon MD; Iyer PG; Anderson LA; Liu G; Wu AH; Dai JY; Chow WH; Risch HA; Lagergren J; Shaheen NJ; Bernstein L; Corley DA; Prenen H; deCaestecker J; MacDonald D; Moayyedi P; Barr H; Love SB; Chegwidden L; Attwood S; Watson P; Harrison R; Ott K; Moebus S; Venerito M; Lang H; Mayershofer R; Knapp M; Veits L; Gerges C; Weismüller J; Gockel I; Vashist Y; Nöthen MM; Izbicki JR; Manner H; Neuhaus H; Rösch T; Böhmer AC; Hölscher AH; Anders M; Pech O; Schumacher B; Schmidt C; Schmidt T; Noder T; Lorenz D; Vieth M; May A; Hess T; Kreuser N; Becker J; Ell C; Ambrosone CB; Moysich KB; MacGregor S; Tomlinson I; Whiteman DC; Jankowski J; Schumacher J; Vaughan TL; Madeleine MM; Hardie LJ; Buas MF
    Carcinogenesis; 2021 Apr; 42(3):369-377. PubMed ID: 33300568
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Long Noncoding RNA hoxa11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met.
    Lin FJ; Lin XD; Xu LY; Zhu SQ
    Mol Cells; 2020 Oct; 43(10):856-869. PubMed ID: 33115978
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. lncRNA hoxa11-AS Promotes Proliferation and Migration via Sponging miR-155 in Hypopharyngeal Squamous Cell Carcinoma.
    Xu J; Bo Q; Zhang X; Lei D; Wang J; Pan X
    Oncol Res; 2020 May; 28(3):311-319. PubMed ID: 31987067
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. LncRNA hoxa11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
    Niu X; Yang B; Liu F; Fang Q
    Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Utility of subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance category in ultrasound-guided thyroid fine-needle aspiration in a large referral cancer center.
    Gan Q; Edeiken BS; Chen MM; Grubbs EG; Busaidy NL; Zafereo M; Perrier ND; Gule-Monroe MD; Krishnamurthy S
    J Am Soc Cytopathol; 2019; 8(6):309-316. PubMed ID: 31526696
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. LncRNA hoxa11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Circulating Long Noncoding RNAs as Biomarkers for Predicting head and neck Squamous Cell Carcinoma.
    Yao Y; Chen X; Lu S; Zhou C; Xu G; Yan Z; Yang J; Yu T; Chen W; Qian Y; Ding S; Tang J; Chen Y; Zhang Y
    Cell Physiol Biochem; 2018; 50(4):1429-1440. PubMed ID: 30355951
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Expression level and clinical significance of LncRNA hoxa11-AS in esophageal squamous cell carcinoma patients].
    Sun XY; Wang XF; Cui YB; Cao XG; Zhao RH; Wei HY; Cao W; Wu W
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):186-190. PubMed ID: 29575836
    [No Abstract]    [Full Text] [Related]  

  • 14. Long non‑coding RNA hoxa11‑AS promotes cell proliferation and metastasis in human breast cancer.
    Su JC; Hu XF
    Mol Med Rep; 2017 Oct; 16(4):4887-4894. PubMed ID: 28791375
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma.
    Buas MF; He Q; Johnson LG; Onstad L; Levine DM; Thrift AP; Gharahkhani P; Palles C; Lagergren J; Fitzgerald RC; Ye W; Caldas C; Bird NC; Shaheen NJ; Bernstein L; Gammon MD; Wu AH; Hardie LJ; Pharoah PD; Liu G; Iyer P; Corley DA; Risch HA; Chow WH; Prenen H; Chegwidden L; Love S; Attwood S; Moayyedi P; MacDonald D; Harrison R; Watson P; Barr H; deCaestecker J; Tomlinson I; Jankowski J; Whiteman DC; MacGregor S; Vaughan TL; Madeleine MM
    Gut; 2017 Oct; 66(10):1739-1747. PubMed ID: 27486097
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma.
    Buas MF; Levine DM; Makar KW; Utsugi H; Onstad L; Li X; Galipeau PC; Shaheen NJ; Hardie LJ; Romero Y; Bernstein L; Gammon MD; Casson AG; Bird NC; Risch HA; Ye W; Liu G; Corley DA; Blount PL; Fitzgerald RC; Whiteman DC; Wu AH; Reid BJ; Vaughan TL
    Carcinogenesis; 2014 Dec; 35(12):2740-7. PubMed ID: 25280564
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis.
    Uchida K; Veeramachaneni R; Huey B; Bhattacharya A; Schmidt BL; Albertson DG
    BMC Cancer; 2014 May; 14():353. PubMed ID: 24886209
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Epigenetic repression of HOXB cluster in oral cancer cell lines.
    Xavier FC; Destro MF; Duarte CM; Nunes FD
    Arch Oral Biol; 2014 Aug; 59(8):783-9. PubMed ID: 24859765
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution.
    Theoharis CG; Schofield KM; Hammers L; Udelsman R; Chhieng DC
    Thyroid; 2009 Nov; 19(11):1215-23. PubMed ID: 19888859
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.